Robert J. Slack

Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis

Nikhil Hirani, Alison C. MacKinnon, Lisa Nicol et al. · European Respiratory Journal · 2020 · 205 citations · Full text

Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis

Alison E. John, Rebecca H. Graves, Kwok‐Tao Pun et al. · Nature Communications · 2020 · 117 citations · Full text

In Vitro Pharmacological Characterization of Vilanterol, a Novel Long-Acting β2-Adrenoceptor Agonist with 24-Hour Duration of Action

Robert J. Slack, Victoria J. Barrett, Valerie S. Morrison et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 111 citations

Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease

Fredrik R. Zetterberg, Alison C. MacKinnon, Thomas Brimert et al. · Journal of Medicinal Chemistry · 2022 · 88 citations · Full text

A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor

Toby M. Maher, Juliet K. Simpson, Joanna C. Porter et al. · Respiratory Research · 2020 · 78 citations · Full text